Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01764984
Other study ID # 5.5.04.12
Secondary ID
Status Completed
Phase Phase 4
First received February 17, 2012
Last updated February 2, 2015
Start date November 2005
Est. completion date January 2015

Study information

Verified date February 2015
Source Centre Hospitalier Universitaire de Québec, CHU de Québec
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Osteoarthritis is a progressive disease afflicting to two thirds of Americans. Today, an estimated 43 million individuals have arthritis. By 2020, more than 59.4 million Americans will be affected by the disease. Despite the relative good track record of total knee replacement, it remains a biomedical device that can fail over time. A recent study looking at the current mechanisms of total knee replacement failures, listed polyethylene wear and osteolysis around implants. The material used for polyethylene insert as well as the conformity of articular surface of implants has been modified to decrease wear. While introducing modularity, the usage of metal backing in tibial base plates became obvious as it offered better stress distribution to the proximal tibial bone. However, it introduced other modes of failures. Micromotion has been demonstrated between the metal backing and the tibial liner, and produced backside polyethylene wear in 44% of implants at retrieval for revision. Factor influencing the surgeon's choice of implant include: reproductibility and longevity of results, technical difficulty of implantation, cost, and impact on bone stock. The modulus of elasticity of the tibial base plate has a direct effect on periprosthetic bone biology. Studies have described a significant decrease in postoperative Bone mineral density (BMD), adjacent to the implants, after total knee replacement. No study, to our knowledge, has looked at BMD in vivo after total knee replacement comparing different tibial base plate designs. Direct effect of changes in design on overall implant survival can be studied with randomized clinical trials isolating specific variables. No randomized clinical trial has looked at tibial insert stiffness and modularity, and it effect on bone density changes, synovitis, osteolysis or survivorship. In order to isolate stiffness and modularity as study variables, one would aim at randomizing an homogenous patient population undergoing total knee arthroplasty with implants of similar articular geometry designs with different tibial insert modularity and stiffness.


Description:

Number of patients: 80 Ages: 55 - 75 years old Sex: male and female Race: all


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date January 2015
Est. primary completion date September 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 55 Years to 75 Years
Eligibility Inclusion Criteria:

- Tri-compartmental knee arthrosis

- 55 to 75 years of age

- Stable health condition

Exclusion Criteria:

- Inflammatory arthritis

- Osteonecrosis

- Infection

- Amputation (AK or BK)

- Biphosphonates

- Metal in the proximal tibia (25cm)

- History of fracture or osteotomy

- Ligament instability

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Total knee arthroplasty
Total knee arthroplasty using parapatellar approach and postero-stabilized implants.

Locations

Country Name City State
Canada Hopital du Sacre-Coeur Montreal Quebec
Canada Hôpital Maisonneuve Rosemont Montreal Quebec
Canada Centre Hospitalier Universitaire de Québec Quebec city Quebec

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Québec, CHU de Québec Zimmer, Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Bone Mineral Density (%) from baseline initial value Evaluation of Bone Mineral Density using dual energy x-ray absorptiometry (DEXA) scan under tibial base plate implant after Total knee arthroplasty. post-operative 7 to 10 days, 6,12,24 months No
Secondary Western Ontario & McMAster University Osteoarthritis sCore (WOMAC)change in time. Standardized clinical evaluation instrument specific to Total knee arthroplasty population. Pre-operative, 6,12,24,60 months No
Secondary number of study subject with implant loosening Radiological evaluation of implant loosening according to Radiographic Knee Society Score at follow-up after total knee arthroplasty. 12, 24, 60 months Yes
Secondary Knee injury and Osteoarthritis Outcome Score (KOOS) change in time. Standardized clinical outcome instruments specific to total knee arthroplasty population. pre-operative, 6,12,24,60 months No
Secondary SF-36 score Standardized General health evaluation and quality of life measuring instrument. Pre-operative, 12,24,60 months No
See also
  Status Clinical Trial Phase
Recruiting NCT02904785 - Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis Phase 2
Completed NCT01364870 - Effect of TENS for Pain and Function After Total Knee Replacement N/A
Completed NCT02285725 - Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid N/A
Recruiting NCT05715645 - Assessment of Recovery After Adductor Canal Block Analgesia in Unilateral Prosthetic Knee Surgery N/A
Not yet recruiting NCT01311804 - An Efficacy and Safety Study of Periarticular Parecoxib Sodium for Pain Management in Total Knee Arthroplasty Phase 3